AzTrials
AzTrials

HealthyNCT07005674

Cycle Nation Communities: Increasing Cycling in Glasgow

A study testing Cycle Nation and Cycling Scotland standard cycling session in people with Healthy, run by University of Glasgow at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomised controlled trial will evaluate the effects of a 9-week multi-component group-based cycling programme (Cycle Nation) versus a standard single cycle training session on self-reported cycling, health and wellbeing outcomes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Cycle Nation and Cycling Scotland standard cycling session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
268 participants
Where
1 siteUnited Kingdom
Study dates
27 May 2025to Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Can ride a bicycle Self-identified infrequent cyclists (currently cycle less than once per month) Aged 18 years or over Willing to provide informed consent Willing to partake in measurements Willing to be randomised to intervention or control arm Have a good understanding of the English language Not have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Able to attend in-person sessions (at least 6 out of 9 sessions) Intend to still be in the UK by November 2026

Who cannot join

  • Cannot cycle (i.e. cannot balance and/or have never learnt to cycle) Frequent or regular cyclists (i.e. currently cycle at least once a month, confident riding on roads) Less than 18 years old Not willing to provide informed consent Not willing to partake in measurements Not willing to be randomised to the intervention or control arm Cannot speak basic English Have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Not able to attend in-person sessions (less than 6 out of 9 sessions) Not intending to still be in the UK by November 2026

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fernanda Gabler Trisotti, PhD contact

07886700868

gallanttravel@glasgow.ac.uk

United Kingdom1 site, 1 recruiting
  • University of Glasgow

    Glasgow

    Fernanda Gabler Trisotti, PhD, 07886700868, gallanttravel@glasgow.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: Effectiveness and Cost-effectiveness of a Community-based Nine-week Multi-component Group-based Cycling Intervention Versus a Single Cycle Training Session to Increase Cycling Participation: the Cycle Nation Communities Randomised Controlled Trial

This randomised controlled trial will evaluate the effects of a 9-week multi-component group-based cycling programme (Cycle Nation) versus a standard single cycle training session on self-reported cycling, health and wellbeing outcomes. Participants are adults that do not regularly cycle, who will be randomly allocated to each arm of the study. Outcomes will be assessed at baseline, post-programme, and at 12 months from baseline. Cost effectiveness will be assessed, and a process evaluation will be conducted.

Read the detailed description

Cycling improves physical and mental health, lowering risks of major diseases and reducing stress while enhancing wellbeing and fitness. It is a time-efficient way to increase physical activity and, when replacing motorised transport, reduces air pollution, carbon emissions, and traffic congestion. However, cycling participation in the UK remains low; only 10% of adults cycle at least weekly. This is a missed opportunity to enhance population health, lower health service costs, reduce environmental impact, and improve health related quality of life. Evidence suggests that over 50% of UK adults are interested in cycling more, therefore the potential to increase cycling is substantial.

Non-cyclists report numerous barriers, spanning the individual, social, and environmental factors of the socio-ecological model. While improvements to cycling infrastructure can address some environmental barriers, they alone are insufficient to drive substantial increases in cycling. While many organisations offer standard single or short-term cycling sessions, these often address isolated components rather than taking an integrated approach. In contrast, Cycle Nation is an integrated group-based 9-week multi-component intervention, targeting multiple individual and social barriers over a sustained period to maximise effectiveness.

Initially co-developed and piloted in collaboration with British Cycling and HSBC-UK as a workplace programme for employees, it has since been adapted for community settings in Manchester and Glasgow. Findings of these studies have demonstrated feasibility, acceptability, and short-term effectiveness. However, Cycle Nation has not yet been rigorously tested in a powered randomised controlled trial (RCT), nor had its long-term effectiveness or cost-effectiveness evaluated.

This is a pragmatic, two-arm RCT to assess the effect of the Cycle Nation programme in comparison to a single cycling training session. The interventions will be delivered by community-based cycling delivery partners across Glasgow, UK, with up to six organisations delivering the Cycle Nation programme (intervention) and one delivering the standard single introduction to road cycling session offered by Cycling Scotland (comparison).

The primary objective is to evaluate the effect of the Cycle Nation programme versus a standard single session on the proportion of participants cycling at least weekly at 12 months. Secondary objectives are to a) to evaluate the effect of the Cycle Nation programme versus a standard cycling session on self-reported health and wellbeing at 12 months, b) to evaluate the within-trial cost-effectiveness of the Cycle Nation programme at 12 months (and longer pending within trial findings), c) to assess how (well) Cycle Nation is delivered and examine how the core causal mechanisms function, and d) to determine how contextual factors contribute to variations in outcome and engagement with the Cycle Nation intervention.

Conditions
Healthy
Being tested
Cycle Nation, Cycling Scotland standard cycling session
Keywords
Cycling, Bicycle, Communities, Randomised controlled trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cycle NationBehavioural

    Participants will be asked to attend nine weekly 90-minute face-to-face sessions, delivered by trained facilitators at community cycling organisations. Sessions include off road cycling skills and on-road group rides, behaviour change techniques (e.g. goal setting), and bicycle maintenance training. Two extra group rides will be offered during the programme for additional practice, along with two catch-up sessions at the end for those who missed any content. Participants will be added to a WhatsApp group to encourage peer communication. Bicycles, helmets, and locks will be loaned to participants for 10-12 weeks to support participation.

  • Cycling Scotland standard cycling sessionBehavioural

    Participants will be asked to participate in Cycling Scotland's 'Introduction to On-Road Cycling' a single 2-2.5-hour session that is offered as standard. The session covers key cycling skills such as hazard awareness, road positioning, and communicating with other road users. Activities are tailored to participants' needs and may include navigating junctions, using shared infrastructure, and performing U-turns. Bicycles and helmets will be provided for the session.

Study groups in NCT07005674
Study groupRoleWhat they receive
Cycle Nation interventionExperimentalNot described
Receives: Behavioral: Cycle Nation
Cycling Scotland standard cycling sessionActive comparatorNot described
Receives: Behavioral: Cycling Scotland standard cycling session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants cycling (for any purpose)

    Change in number (proportion) of participants cycling (for any purpose) over past four weeks at 12 months

    Measured: From baseline to 12 months follow-up

Secondary outcomes (24)
  1. Proportion of participants cycling (for any purpose)

    Change in number (proportion) of participants cycling (for any purpose) over past four weeks at 12-weeks follow-up

    Measured: From baseline to 12 weeks follow-up

  2. Number of cycling journeys (for any purpose)

    Change in the number of cycling journeys (for any purpose) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12-weeks and 12-months follow-up

  3. Number of cycling journeys (leisure)

    Change in the number of cycling journeys (for leisure) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  4. Number of cycling journeys (commuting)

    Change in the number of cycling journeys (for commuting) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  5. Number of cycling journeys (errands)

    Change in the number of cycling journeys (for errands) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  6. Total duration of weekly cycling (for any purpose)

    Change in total duration (minutes) of weekly cycling (for any purpose) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  7. Total duration of weekly cycling (leisure)

    Change in total duration (minutes) of weekly cycling (for leisure) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  8. Total duration of weekly cycling (commuting)

    Change in total duration (minutes) of weekly cycling (for commuting) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  9. Total duration of weekly cycling (errands)

    Change in total duration (minutes) of weekly cycling (for errands) over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  10. Number of private car journeys

    Change in time of private car journeys over past four weeks at 12 weeks and at 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  11. Number of taxi journeys

    Change in the number of taxi journeys over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  12. Total duration of taxi journeys

    Change in total duration (minutes) of weekly taxi journeys over past four weeks at 12-weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  13. Number of public transport journeys

    Change in the number of weekly public transport journeys over past four weeks at 12 weeks and at 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  14. Total duration of public transport journeys

    Change in total duration (minutes) of weekly public transport journeys over past four weeks at 12-weeks and at 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  15. Number of walking journeys

    Change in the number of walking journeys over past four weeks at 12 weeks and at 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  16. Total duration of walking journeys

    Change in total duration (minutes) of walking journeys over past four weeks at 12-weeks and at 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  17. Perception of cycling safety

    Change in perception of cycling safety at 12 weeks and 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  18. Perceptions of environment

    Change in perception of environment at 12 weeks and 12 months follow-up

    Measured: From baseline to 12 weeks and 12 months follow-up

  19. Confidence to cycle

    Change in confidence to cycle at 12 weeks and 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  20. Motivation for cycling

    Change in motivation (intrinsic motivation, identified regulation, introjected regulation, external regulation, and amotivation for exercise) using the Behavioural Regulation in Exercise Questionnaire (BREQ-2) at 12 weeks and 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  21. Self-esteem

    Change in self-esteem (Rosenberg Self-Esteem Questionnaire) at 12 weeks and 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  22. Vitality

    Change in vitality score (Subjective Vitality Scale) at 12 weeks and 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  23. Health related quality of life

    Change in health-related quality of life score (EQ-5D-5 L) at 12 weeks and 12 months

    Measured: From baseline to 12 weeks and 12 months follow-up

  24. Capability wellbeing

    Change in capability wellbeing score (ICECAP-A) at 12 weeks and 12 month

    Measured: From baseline to 12 weeks and 12 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2025
  2. Study start27 May 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial with two groups, Cycle Nation programme and Cycling Scotland single standard cycling session
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
268 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07005674
Sponsor's protocol ID
200240325
Other IDs
NE/W005042/1
Status last verified
Oct 2025
First submitted
22 May 2025
Last updated
7 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: At the end of the project, anonymised/pseudonymised/de-identified research data will be deposited with the UK Data Service ReShare Repository.

Publications

  • Connell H, Logan G, Somers C, Baker G, Broadfield S, Bunn C, Harper LD, Kelly P, McIntosh E, Pell JP, Puttnam J, Robson S, Gill JMR, Gray CM. Development and optimisation of a multi-component workplace intervention to increase cycling for the Cycle Nation Project. Front Sports Act Living. 2022 Oct 26;4:857554. doi: 10.3389/fspor.2022.857554. eCollection 2022.

    PubMed 36385778
  • Kelly P, Williamson C, Baker G, Davis A, Broadfield S, Coles A, Connell H, Logan G, Pell JP, Gray CM, Gill JM; Cycle Nation Project. Beyond cycle lanes and large-scale infrastructure: a scoping review of initiatives that groups and organisations can implement to promote cycling for the Cycle Nation Project. Br J Sports Med. 2020 Dec;54(23):1405-1415. doi: 10.1136/bjsports-2019-101447. Epub 2020 Apr 8.

    PubMed 32269057
  • Lawlor ER, Gabler Trisotti MF, McIntosh E, McConnachie A, Gill JMR, Gray CM. Effectiveness and cost-effectiveness of a 9 week multi-component cycling programme versus an existing single cycling training session: protocol for the Cycle Nation Communities randomised controlled trial. BMJ Open. 2026 Mar 3;16(3):e112768. doi: 10.1136/bmjopen-2025-112768.

    PubMed 41775482

Questions about this trial

What is this clinical trial studying?

A study testing Cycle Nation and Cycling Scotland standard cycling session in people with Healthy, run by University of Glasgow at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fernanda Gabler Trisotti, PhD (07886700868, gallanttravel@glasgow.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants cycling (for any purpose) (time frame: From baseline to 12 months follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07005674, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in